Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Share-based Compensation came in at $38.0 million in Q2 2026, up 26.67% on a YoY basis from $30.0 million in Q2 2025, and up 11.76% quarter-over-quarter from $34.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Share-based Compensation (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Share-based Compensation for 6 consecutive years, with $38.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 26.67% year-over-year to $38.0 million; the trailing twelve-month figure through Jun 2026 stood at $163.0 million (up 49.54% YoY), and the FY2025 full-year result was $149.0 million, up 61.96% from the prior year.
- Share-based Compensation advanced to $38.0 million in Q2 2026 per BLCO's latest filing, from $34.0 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $64.0 million in Q4 2025 and bottomed at $11.0 million in Q2 2022.
- Historically, Share-based Compensation has averaged $24.9 million across 5 years, with a median of $23.0 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation fell 26.67% in 2022, then jumped 137.04% in 2025.
- Over 5 years, Share-based Compensation stood at $17.0 million in 2022, then declined by 5.88% to $16.0 million in 2023, then soared by 68.75% to $27.0 million in 2024, then surged by 137.04% to $64.0 million in 2025, then plunged by 40.62% to $38.0 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $38.0 million, $34.0 million, and $64.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 38.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | 64.00 Mn |
| Sep 30, 2025 | 27.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 28.00 Mn |
| Dec 31, 2024 | 27.00 Mn |
| Sep 30, 2024 | 24.00 Mn |
| Jun 30, 2024 | 22.00 Mn |
| Mar 31, 2024 | 19.00 Mn |
| Dec 31, 2023 | 16.00 Mn |
| Sep 30, 2023 | 16.00 Mn |
| Jun 30, 2023 | 18.00 Mn |
| Mar 31, 2023 | 24.00 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Jun 30, 2022 | 11.00 Mn |
| Mar 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | 17.00 Mn |
| Sep 30, 2021 | 16.00 Mn |